More than 806 loss-of-function variants in bone morphogenetic protein receptor type II (BMPR2) have been identified, which account for 75% and 25% of heritable PAH (HPAH) and IPAH cases, respectively [24,25]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.